Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Citius Pharmaceuticals
Citius Pharmaceuticals
(CTXR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Suprenza
Phentermine
2011-06-13
2028-2029
Obesity
,
Pain
,
Epilepsy
,
Lennox gastaut syndrome
,
Infantile spasms
,
Partial epilepsies
,
Tonic-clonic epilepsy
,
Bipolar disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bos taurus adrenal cortex corticosteroids
graft rejection
,
neoplasms
,
liver transplantation
,
circulating neoplastic cells
,
pulmonary eosinophilia
,
uveitis
,
heart transplantation
,
liver diseases
,
duchenne muscular dystrophy
,
muscular dystrophies
,
histiocytosis
,
langerhans-cell histiocytosis
,
crohn disease
,
bronchiolitis obliterans
,
bronchiolitis
,
syndrome
,
atopic dermatitis
,
dermatitis
,
lung diseases
,
eczema
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
rhinosinusitis
,
inflammation
,
thrombotic thrombocytopenic purpura
,
thrombocytopenic purpura
,
purpura
,
nasal polyps
,
graft vs host disease
,
bronchiolitis obliterans syndrome
,
osteoarthritis
,
neurodermatitis
,
prurigo
,
polyps
,
bullous pemphigoid
,
pemphigus
,
allergic fungal sinusitis
,
asthma
,
kidney transplantation
,
prostatic neoplasms
,
hyperglycemia
,
transplantation
,
chronic kidney failure
,
knee osteoarthritis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use